Faraday Pharmaceuticals
Catherine Hutt has been working in the clinical operations field since 1996. Catherine began their career at SciClone Pharmaceuticals as a Clinical Research Associate, and then moved to MedImmune in 2002 to take on the same role. In 2003, they joined Genentech as a Sr. Country Study Manager, and later became a Sr. Global Study Manager and Clinical Trial Manager. In 2021, they were hired as a Senior Clinical Study Manager at BeiGene, and is currently employed as an Associate Director of Clinical Operations at Faraday Pharmaceuticals, Inc.
Catherine Hutt has a Master's degree in Counseling Psychology from Notre Dame de Namur University and a Bachelor's degree in Psychology from California State University-Sacramento. Catherine also holds a certification in Adult and Pediatric First Aid/CPR/AED from the American Red Cross, which they obtained in August 2019.
This person is not in any offices
Faraday Pharmaceuticals
Faraday Pharmaceuticals' mission is to improve the quality of life for patients after acute critical illness by minimizing damage to cardiac and skeletal muscle.